MAP3K8 anticorps (pThr290) (Biotin)

N° du produit ABIN1955229

Cet anticorps anti-MAP3K8 est un anticorps Lapin Polyclonal détectant MAP3K8 dans ELISA et DB. Adapté pour Humain.

Aperçu rapide pour MAP3K8 anticorps (pThr290) (Biotin) (ABIN1955229)

Antigène: MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAP3K8 est conjugé à/à la Biotin

Application: ELISA, Dot Blot (DB)

Détail du produit anti-MAP3K8 anticorps (Biotin)

Épitope: pThr290

Specificité: This MAP3K8 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T290 of human MAP3K8.

Purification: Immunoaffinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: DB, ELISA

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Date de péremption: 6 months

Détails sur MAP3K8

Antigène: MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))

Autre désignation: MAP3K8 / TPL2

Sujet: Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase

Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF

ID gène: 1326

Pathways: Signalisation PI3K-Akt, TCR Signaling